IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q1 2019 Holdings

Filed 2019-05-15 | 18 holdings | $2.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$1.5M6,36876.3%
Quidel CorpCOM74838J101$124.6K1,903,5586.3%
Amarin Corp PLCSPONS ADR NEW023111206$108.5K5,226,5805.5%
Accelerate Diagnostics IncCOM00430H102$91.4K4,349,5634.6%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$52.6K1,021,3922.7%
Dermira Inc(DERMEUR)COM24983L104$18.5K1,367,4360.9%
Biolase IncCOM NEW090911207$14.7K6,173,2500.7%
Vermillion IncCOM NEW92407M206$11.3K9,825,2890.6%
Motus GI Hldgs IncCOM62014P108$10.8K2,775,0000.5%
Opko Health Inc(OPK)COM68375N103$9.6K3,686,1940.5%
Pacific Biosciences Calif in(PACB)COM69404D108$8.0K1,110,6660.4%
Soleno Therapeutics IncCOM NEW834203200$7.9K3,813,5580.4%
Agenus Inc(AGENEUR)COM NEW00847G705$4.0K1,358,9180.2%
Biohaven Pharmactl Hldg Co L(BHVN)CallCOMG11196105$3.4K739,0000.2%
Contrafect Corp(CFRXEUR)COM212326102$2.2K5,621,1990.1%
Amarin Corp PLCCallSPONS ADR NEW023111206$410165,4000.0%
Accelerate Diagnostics IncCallCOM00430H102$377206,4000.0%
Pacific Biosciences Calif in(PACB)CallCOM69404D108$13500,0000.0%